IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations

NCT06487377 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Colorectal Cancer

Interventions

BIOLOGICAL: IX001 TCR-T cells

Sponsor

Shanghai Pudong Hospital

Collaborators

[object Object]